TNF-α expression and herpes simplex infection in human monocytes treated with growth hormone, prolactin and insulin

New Microbiologica

Volumn 21, Issue 3, 1998, Pages 213-220

  Cipollaro De L'Ero, G ^a   Marcatili, A ^a   Folgore, A ^a   Donnarumma, G ^a   Petrillo, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Growth hormone; Herpes simplex; Insulin; Prolactin; TNF expression

Indexed keywords

GROWTH HORMONE; INSULIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CERCOPITHECUS; DRUG EFFECT; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; METABOLISM; MONOCYTE; SENSITIVITY AND SPECIFICITY; SHEEP; SWINE; VERO CELL; VIROLOGY; VIRUS CULTURE;

ANIMALS; CATTLE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; GROWTH HORMONE; HERPESVIRUS 1, HUMAN; HUMANS; INSULIN; LIPOPOLYSACCHARIDES; MONOCYTES; PLAQUE ASSAY; PROLACTIN; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SHEEP; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS;

EID: 0032114219     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. AGGARWAL, B.B., KOHR, W.J., HASS, P.E., MOFFAT, B., SPENCER, S.A., HENZEL, W.J., BRINGMAN, T.S., NEDWIN, G.E., GOEDDEL, D.V., and HARKINS, R.N. (1985). Human tumor necrosis factor: production, purification, and characterization. Journal of Biological Chemestry, 260, 2345-2354.
2. ARAI, K., LEE, F., MIYAJIMA, A., SHOICHIRO, M., ARAI, N., and YOKOTA, T. (1990). Cytokines: coordinators of immune and inflammatory responses. Annual Review of Biochemestry, 59, 783-793.
3. AREND, W.P., GORDON, D.F., WOOD, W.M., JANSON, R.W., JOSLIN, F.G., and JAMEEL, S. (1989). IL-1ß production in cultured human monocytes is regulated at multiple levels. Journal of Immunology, 143, 118-126.
4. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SMITH, J.A., SEIDMAN, J.D., and STRUHL, K. (1987). Current protocols in molecular biology. Greene Publishing Associates, John Wiley & Sons, New York.
5. BENEDETTO, N., FOLGORE, A., GALDIERO, M., MELI, R., and DI CARLO, R. (1995). Effect of prolactin. rIFN-α or rTNF-α in murine toxoplasmosis. Pathology and Biology, 43, 395.
6. BERNTON, E.W., MELTZER, M.S., and HOLADAY, J.W. (1988). Suppression of macrophage activation and lymphocyte function in hypoprolactinemic mice. Science, 239, 401-404.
7. BESEDOVSKY, H., and SORKIN, E. (1977). Network of immune-neuroendocrine interactions. Clinical Experimental Immunology, 27, 323-325.
8. BEUTLER, B., KRAKIN, N., MILSARK, I.W., LUEDIKE, C., and CERAMI, A. (1986). Control of cachectin (Tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science, 232, 977-990.
9. BRAUN, R.W., TEUTE, H.K., KIRSCHNER, H., and MUNK, K. (1984). Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. Journal of Immunology, 132, 914-918.
10. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analatical Biochemestry, 162, 156-159.
11. DI CARLO, R., MELI, R., GALDIERO, M., NUZZO, I., BENTIVOGLIO, C., and ROMANO CARRATELLI, C. (1993). Prolactin protection against lethal effects of Salmonella typhimurium. Life Sciences, 53, 981-986.
12. DINARELLO, C.A., CANNON, J.C., WOLFF, S.M., BERNHEIM, H.A., BEUTLER, B., CERAMI, A., FIGARI, I.S., PALLADINO, JR. M.A., and O'-CONNOR, J.W. (1986). Tumor necrosis factor (cachetin) is an endogenous pyrogen and induces production of interleukin-1. Journal of Experimental Medicine, 163, 1433-1450.
13. DUGUESNOY, R.J. (1972). Immunodeficiency of the thymus-dependent system of the Ames dwarf mice. Journal of Immunology, 108, 1578-1582.
14. EDWARDS, C.K. 3D., YUNGER, L.M., LORENCE, R.M., DAUTZER, R., and KELLEY, K.W. (1991). The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proceedings of National Academy of Science USA, 88, 2274-2275.
15. FABRIS, N., PIERPAOLI, W., and SORKIN, E. (1971). Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome on the dwarf mouse. Clinical Experimental Immunology, 9, 227-240.
16. FLAMAND, L., GOSSELIN, J., D'ADDARIO, M., HISCOTT, J., ABLASHI, D.V., GALLO, R.C., and MENEZES, J. (1991). Human herpesvirus 6 induces interleukin-1ß and tumor necrosis factor alpha, but not interleukin-6 in peripheral blood mononuclear cell cultures. Journal of Virology, 65, 5105-5110.
17. FREUDEMBERG, M.A., KEPPLER, D., and GALANOS, C. (1986). Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infection and Immunity, 51, 891-895.
18. GOSSELIN, J., FLAMAND, L., D'ADDARIO, M., HISCOTT, J., STEFANESCU, I., ABLASHI, D.V., GALLO, R.C., and MENEZES, J. (1992). Modulatory effects of Epstein-Barr, Herpes simplex and human Herpes-6 viral infections and coinfections on cytokine synthesis. Journal of Immunology, 149, 181-187.
19. HELDERMAN, J.H., REYNOLDS, T.C., and STROM, T.B. (1978). The insulin receptor as a universal marker of activated lymphocytes. European Journal of Immunology, 8, 589-595.
20. HELDERMANN, G.H., and STROM, T.B. (1978). Specific insulin binding sites on T and B lymphocytes as a marker of cell activation. Nature, 274, 62-64.
21. LIDBURY, B.A., RAMSHAW, I.A., ROLPH, M.S., and COWDEN, W.B. (1995). The antiviral activity of tumor necrosis factor on herpes simplex virus type I: role for a butylated hydroxyanisole sensitive factor. Archives of Virology, 140, 703-719.
22. MESTAN, J., DIGEL, W., MITTMACHT, S., HILLEN, H., BLOHM, D., MOLLER, A., JACOBSEN, H., and KIRCHNER, H. (1986). Antiviral effects of recombinant tumor necrosis factor in vitro. Nature, 323, 816-819.
23. PIERPAOLI, W., and SORKIN, E. (1968). Hormones and immunologic capacity. I. Effect of heterologous antigrowth hormone (ASTH) antisera on thymus and peripheral lymphatic tissue in mice. Induction of a wasting syndrome. Journal of Immunology, 101, 1036-1043.
24. RAYFIELD, E.J., AULT, M.J., KEUSCH, G.T., BROTHERS, M.J., NECHEMIAS, C., and SMITH, H. (1982). Infection and diabetics: the case for glucose control. American Journal of Medicine, 72, 439-450.
25. RUSSELL, D.H., MATRISIAN, L., KIBLER, R., LARSON, D.F., POULOS, B., and MAGUN, B.E. (1984). Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochemical and Biophysical Research Communication, 121, 899-906.
26. RUSSELL, D.H., MATRISIAN, L., KIBLER, R., LARSON, D.F., POULOS, B., and MAGUN, B.E. (1985). Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. Journal of Immunology, 134, 3027-3031.
27. SARIBAN, E., IMAMURA, K., LUEBBERS, R., and KUFE, D. (1988). Transcriptional and post-transcriptional regulation of tumor necrosis factor gene expression in human monocytes. Journal of Clinical Investigation, 81, 1506-1510.
28. SNOW, E.G. (1985). Insulin and growth hormone function as minor growth factors that potentiate lymphocyte activation. Journal of Immunology, 135, 776-778.
29. WONG, J.H.V., and GOEDDEL, D.V. (1986). Tumor necrosis factor α and α inhibit virus replication and synergize with interferons. Nature, 323, 819-822.